Avinger (NSDQ:AVGR) said today it signed an agreement with group purchasing organization HealthTrust for Avinger’s portfolio of peripheral artery disease products.
Through the deal, HealthTrust members will be able to purchase Avinger’s Pantheris optical coherence tomography image-guided atherectomy system and other products designed to treat peripheral artery disorder.
The Pantheris device is designed to use optical coherence tomography to allow physicians to visualize the vessel and obstruction during atherectomy procedures to treat peripheral artery disease.
“Better treatment options are needed for patients suffering from peripheral artery disease, who endure painful symptoms and, if left untreated, are at increased risk of heart attack and stroke. We are excited that our technologies will now be available to more providers through this agreement with HealthTrust,” prez & CEO Jeff Soinski said in a press release.